Pharmacokinetic study of a systemically administered novel liposomal Temoporfin formulation in an animal tumor model
(2007) Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XVI 6427. p.4270-4270- Abstract
- Meso-tetra(hydroxyphenyl)chlorin (mTHPC) (international generic name Temoporfin) is a potent photosensitizer used for photodynamic therapy (PDT). In this study the pharmacokinetics of a systemically administered novel lipid formulation of Temoporfin in a murine tumor model has been investigated. Fluorescence spectroscopy measurements were performed at several time intervals following drug administration, yielding information on the Temoporfin concentration within excised internal organs as a function of time after injection. Both point-monitoring and imaging setups were used. The acquired fluorescence data were correlated to the concentration of Temoporfin obtained with High Performance Liquid Chromatography (HPLC). There was a significant... (More)
- Meso-tetra(hydroxyphenyl)chlorin (mTHPC) (international generic name Temoporfin) is a potent photosensitizer used for photodynamic therapy (PDT). In this study the pharmacokinetics of a systemically administered novel lipid formulation of Temoporfin in a murine tumor model has been investigated. Fluorescence spectroscopy measurements were performed at several time intervals following drug administration, yielding information on the Temoporfin concentration within excised internal organs as a function of time after injection. Both point-monitoring and imaging setups were used. The acquired fluorescence data were correlated to the concentration of Temoporfin obtained with High Performance Liquid Chromatography (HPLC). There was a significant correlation between the fluorescence methods and HPLC for most organs investigated. The pharmacokinetics of this new liposomal formulation of Temoporfin exhibited a rather flat temporal profile in the time interval 2-8 hours in this study. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/643404
- author
- Svensson, Jenny LU ; Johansson, Ann LU ; Bendsöe, Niels LU ; Grafe, Susanna ; Trebst, Tilmann ; Andersson-Engels, Stefan LU and Svanberg, Katarina LU
- organization
- publishing date
- 2007
- type
- Chapter in Book/Report/Conference proceeding
- publication status
- published
- subject
- keywords
- Flat temporal profile, Temoporfin, Liposomal formulation
- host publication
- Progress in Biomedical Optics and Imaging - Proceedings of SPIE
- volume
- 6427
- pages
- 4270 - 4270
- publisher
- SPIE
- conference name
- Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XVI
- conference location
- San Jose, CA, United States
- conference dates
- 2007-01-20 - 2007-01-21
- external identifiers
-
- wos:000246489700020
- scopus:34548238711
- ISSN
- 1042-4687
- 1605-7422
- DOI
- 10.1117/12.698932
- language
- English
- LU publication?
- yes
- id
- 0f3c79a1-f3cd-4147-bd94-dc85e9dd199f (old id 643404)
- date added to LUP
- 2016-04-01 12:24:49
- date last changed
- 2025-01-02 17:04:07
@inproceedings{0f3c79a1-f3cd-4147-bd94-dc85e9dd199f, abstract = {{Meso-tetra(hydroxyphenyl)chlorin (mTHPC) (international generic name Temoporfin) is a potent photosensitizer used for photodynamic therapy (PDT). In this study the pharmacokinetics of a systemically administered novel lipid formulation of Temoporfin in a murine tumor model has been investigated. Fluorescence spectroscopy measurements were performed at several time intervals following drug administration, yielding information on the Temoporfin concentration within excised internal organs as a function of time after injection. Both point-monitoring and imaging setups were used. The acquired fluorescence data were correlated to the concentration of Temoporfin obtained with High Performance Liquid Chromatography (HPLC). There was a significant correlation between the fluorescence methods and HPLC for most organs investigated. The pharmacokinetics of this new liposomal formulation of Temoporfin exhibited a rather flat temporal profile in the time interval 2-8 hours in this study.}}, author = {{Svensson, Jenny and Johansson, Ann and Bendsöe, Niels and Grafe, Susanna and Trebst, Tilmann and Andersson-Engels, Stefan and Svanberg, Katarina}}, booktitle = {{Progress in Biomedical Optics and Imaging - Proceedings of SPIE}}, issn = {{1042-4687}}, keywords = {{Flat temporal profile; Temoporfin; Liposomal formulation}}, language = {{eng}}, pages = {{4270--4270}}, publisher = {{SPIE}}, title = {{Pharmacokinetic study of a systemically administered novel liposomal Temoporfin formulation in an animal tumor model}}, url = {{https://lup.lub.lu.se/search/files/2913011/2370797.pdf}}, doi = {{10.1117/12.698932}}, volume = {{6427}}, year = {{2007}}, }